Sino Biological US Inc
 

« Previous article
Reagents for Immunod...

11th March 2025  Content supplied by: Sino Biological US Inc.

Reagents for 2025-2026 Influenza Vaccine Strains


Vaccination is the most effective way to prevent flu infection. Each year, several different flu strains are selected as vaccine candidates based on surveillance data of the recent isolates and the performance of the vaccines from the previous season. In recent decades, most influenza vaccines are trivalent or quadrivalent, composed of one H1N1, one H3N2, and either one or two type B viruses (Yamagata and Victoria lineage).

Sino Biological offers recombinant flu antigen products under its ProVir® viral antigen collection. The product line covers Hemagglutinin (HA), Neuraminidase (NA), and Nucleoprotein (NP) proteins from all WHO-recommended vaccine strains of recent years. These antigens can be used to analyze vaccine-induced antibody response. In addition, Sino Biological has also developed an extensive collection of monoclonal antibodies against the flu antigens. These reagents can help facilitate relevant assay development.

Order Now


Share on:

Tags:


Date Published: 11th March 2025

Source article link: View


View full company details




Sino Biological US Inc.

Address:

Wayne, PA 19087

United States

Tel: +1 215-583-7898

Email Supplier

View full company details


Related news from Sino Biological US Inc.